Kynam Capital Management, LP Ironwood Pharmaceuticals Inc Transaction History
Kynam Capital Management, LP
- $1.19 Billion
- Q1 2025
A detailed history of Kynam Capital Management, LP transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Kynam Capital Management, LP holds 5,822,938 shares of IRWD stock, worth $4.66 Million. This represents 0.72% of its overall portfolio holdings.
Number of Shares
5,822,938
Previous 4,685,563
24.27%
Holding current value
$4.66 Million
Previous $20.8 Million
58.77%
% of portfolio
0.72%
Previous 1.32%
Shares
5 transactions
Others Institutions Holding IRWD
# of Institutions
222Shares Held
167MCall Options Held
11.2MPut Options Held
6.9K-
Black Rock Inc. New York, NY22.9MShares$18.3 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$13.1 Million6.58% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.7MShares$12.6 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY13.7MShares$11 Million0.31% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.94MShares$7.95 Million0.02% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $123M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...